Fundz
Real-time · AI · Cross-signal

GondolaBio just moved. Here's exactly what to do next.

Who to reach, what to say, and why now — on GondolaBio, plus every contract, funding round, and exec hire that follows, each with verified, ICP-ranked contacts.

Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.

Get the full Deep Dive on GondolaBio — free.

We'll email your report. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

▶
Watch the 2-minute tour · with sound
Don’t take our word for it — ask the live AI about GondolaBio, free
Try the live AI on GondolaBio — no signupNo signup to start
Your turn — ask anything about GondolaBio and hit Ask. Your first answer is free, no signup.
Tap one:

GondolaBio and n-Lorem Foundation Partner to Advance Novel ASO Therapies for Genetic Diseases

Dec 17, 2024•over 1 year ago

Contract Type

partnership

San DiegoBiotechnologyHealth CareTherapeutics

Description

n-Lorem, a nonprofit foundation, and GondolaBio have entered into multiple collaborations to discover novel ASO medicines for patients who are not currently served by available treatment options. n-Lorem will leverage its robust, automated, high-capacity ASO discovery platform and significant expertise in ASO technology to discover, screen and select ASO medicines to two prespecified biological targets in genetic diseases with significant unmet need. GondolaBio will move forward in the development of these new medicines.

Company Information

Company

GondolaBio

Location

San Diego, California, United States

About

GondolaBio is a clinical-stage biotechnology company founded in 2024 and dedicated to developing novel medicines for patients living with genetic diseases.

Predictive Intelligence
Strategic

ML-powered predictions for GondolaBio's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.